Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 268 participants.

Also called NCT05655468

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 268 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05655468
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05655468. Randomized; quadruple masking; primary purpose treatment. Start 2023-03-29 (actual); primary completion 2025-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation
Acronym
DORIS
Intervention (Drug)
Dronedarone
Intervention (Drug)
Placebo
Lead sponsor
Shanghai East Hospital (class: other)

Record details

Record id
cardio:ct-nct05655468
Content hash
6aa2d9eb43b80888fcd7cb56a80da49324e5245c2d0e4be0670ff27c9c979ac5